The Latest Breaking News from ABT

Van der Linde had moved into the lead of Sunday’s DTM race thanks to a brilliant overcut strategy executed by Abt Sportsline, jumping both team-mate Ricardo Feller and Manthey EMA driver Preining.

Manthey EMA’s Preining fell behind both van de Linde and Feller at one stage, but quickly repassed the Abt Audi duo to claim his first win of the 2024 season and move up to second in the standings.

Abbott Laboratories' Q4 earnings report and stock performance analysis, highlighting limited growth potential.

Abbott's earnings guidance slightly missed expectations at the midpoint Wednesday, and ABT stock fell within a saucer base.

The medical sector is poised for substantial gains this year, fueled by rising cases of chronic diseases and swift technological progress. In light of this, let’s analyze the fundamentals of three medical stocks: Abbott Laboratories (ABT), Agilent Technologies (A), and Viemed Healthcare (VMD). Read on….

During the Mexico City E-Prix race meeting, it was revealed that Abt had terminated its contract with Mahindra on the eve of the season-opener, with the collaboration set to finish at the end of 2024.

During the Mexico City E-Prix race meeting it was revealed that Abt had terminated its contract with Mahindra on the eve of the season-opener, with the collaboration set to finish at the end of 2024.

There was a great degree of surprise in the DTM paddock when Abt took the covers off its 2024 challenger at the Hockenheim finale last month. A shiny new Audi R8 LMS was showcased late in the evening to a huge hoard of photographers and journalists, with the car sporting…

Essentially a track car with a license plate, the ABT XGT routes 630 horsepower to the rear wheels.